More news about PB&B

PB&B awarded at world’s largest medical aesthetics event

07.02.2018 17:10

Related tags


Last weekend, PB&B has been awarded with the title of “IMCAS Innovation of the Year” in Paris. A record 8000 delegates, from dermatology, plastic surgery, and related professions, attended the conference. 

PB&B is a Swiss Medtech startup developing a new generation of fillers and soft tissue remodeling injections for plastic surgeons and dermatologists. The company’s patented technology stimulates a patient’s soft tissues in situ to naturally gain volume with locally delivered lipids.

With this technology PB&B competed against eight other start-ups from all over the world ath the IMCAS 2018 World Congress. The jury included investors, industry leaders and physicians and in the end selected PB&B as the winner.

“The 3 days congress in Paris is the biggest medical aesthetics event for both the industry and medical community”, explains Anthony Aho, CEO & co-founder PB&B SA, to Startupticker, “it is where new products and technologies are showcased, as well as best medical practices are demonstrated at times live directly on patients - it is a kind of CES Show for Plastic Surgery & Anti-aging Science”.


Please login or
register to comment

Please login or sign up to comment. Commenting guidelines


A showcase for female CEOs

Startupticker has recorded Swiss start-ups with female CEOs and ranked them by sector. The map which includes links to 80+ companies can be downloaded in our article.



By continuing to use this website you agree with our TERMS AND CONDITIONS